MindMed Joins Digital Medicine Society to Improve Health Outcomes and Equity Using Technology
DATAcc members, including Dr. Dan Karlin, Chief Medical Officer of MindMed, will meet for the rst time today, marking the launch of this collaborative community dedicated to realizing the full potential of digital health measurement as a powerful new tool to drive improvements in health outcomes, health economics, and health equity.
- DATAcc members, including Dr. Dan Karlin, Chief Medical Officer of MindMed, will meet for the rst time today, marking the launch of this collaborative community dedicated to realizing the full potential of digital health measurement as a powerful new tool to drive improvements in health outcomes, health economics, and health equity.
- "DATAcc can advance efforts to build the science and evidence generation for all people by keeping health outcomes and health equity front and center."
- Dr. Daniel Karlin, Chief Medical Officer of MindMed, added, "We are eager to advance the science of digital medicine through cooperation and collaboration.
- MindMed is a clinical-stage biotech company that discovers, develops and deploys psychedelic inspired medicines and therapies to address addiction and mental health.